Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

▤ Summary

Stanford researchers are presenting work on autonomous AI scientist agents that can support drug discovery across the full development lifecycle. The system uses a hierarchical orchestration model, with specialized agents handling discovery, safety, and analysis while preserving context across long workflows. The team ties the agents to multiple primary data sources, including genomics, FDA chemistry data, and clinical trial databases. The article also notes that James Zou is raising money for a startup, Human Intelligence, at a reported $1 billion valuation, and that he will discuss the approach at VB Transform 2026.

▦ Linked Companies